Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology

Inclusion Criteria: * 18 years old or more * Performance status from 0 to 4 * Patient treated followed for histologically confirmed solid tumor type of any of these localization : breast, prostate, uterus, ovary, colon, lung, head and neck, melanoma. * Informed consent form signed. Exclusion Criteria: * Patient with history of other invasive cancer within 5 years. * Patient treated for any non-invasive cancer * Patient individually deprived of liberty or placed under the authority of a tutor * Geographical condition potentially preventing compliance with the study protocol.